|
ERT/HRT relieves menopause symptoms and has been shown to have beneficial effects on both bone health and cardiovascular health. Side effects may include nausea, bloating, breast tenderness and high blood pressure. Some studies indicate a relationship between estrogen use and breast cancer, while other studies indicate no relationship at all. The issue of a relationship between breast cancer and estrogen use is still to be determined. As individual circumstances differ, you must discuss the pros and cons of ERT with your doctor.
The latest pain killer for osteoporosis In the West, the Food and Drug Administration approved a new painkiller to treat osteoporosis. The generic name of the drug is meloxicam and will be marketed by Boehringer Ingelheim and Abbott Laboratories. This drug, while being tested, appears to cause comparatively lower incidence of gastrointestinal side effects.
|